It is reported that the nine price HPV vaccine has been approved for marketing in China. According to the State Drug Administration, the nine valent human papillomavirus vaccine (HPV vaccine for short) for cervical cancer prevention has the conditions to be approved for marketing.
On April 29, the official website of the State Drug Administration issued the notice of conditional approval for the listing of nine valent human papillomavirus vaccine. The article points out that on April 28, 2018, the State Drug Administration had the conditions to approve the listing of the nine valent human papillomavirus vaccine (hereinafter referred to as HPV vaccine) for the prevention of cervical cancer.
Friends who have known about cervical cancer vaccine know that bivalent and quadrivalent vaccines have been listed one after another, and they can make an appointment for vaccination in Beijing.
Beijing HPV vaccine pre appointment entrance
Small partners can pay attention to official WeChat public number, WeChat dialog box reply [vaccine] to see the address of community health service center and telephone to make an appointment.
Can you brush medical insurance for cervical cancer vaccine?
Three doses of bivalent and tetravalent HPV vaccines have been approved in mainland China. Self paid vaccine cannot go through medical insurance~
Can you choose any vaccination point?
In addition to the special clinic, if you choose the community vaccination clinic, please go to the home where you live. If you need Cross Street (town) vaccination, please contact the relevant community health service center in advance.
What documents do you need to bring with you for vaccination?
Please bring your ID card.
Note: there is no household registration restriction for vaccination and no residence permit is required. It is suggested to make an appointment first, and bring your ID card to vaccinate after the appointment is successful. For details, please consult the vaccinated hospital!
Nine valent vaccine for women aged 16 to 26
HPV is the abbreviation of human papillomavirus. There are more than 100 members in HPV family, some of them are called high risk HPV.
At present, there are three kinds of HPV vaccines on the market in the world: bivalent, tetravalent and ninvalent. The 'Valence' represents the types of virus that can be prevented by vaccines. Bivalent and bivalent vaccines can prevent and control 84.5% of cervical cancer risk, while bivalent and bivalent vaccines can prevent 92.1% of cervical cancer. The vaccine is usually administered three times for six months before it takes effect.
The approved nine price HPV vaccine is suitable for women aged 16 to 26 years old to prevent cervical cancer, vulvar cancer, vaginal cancer, anal cancer, genital warts, persistent infection, precancerous lesions or atypical lesions caused by HPV.
If there is hypersensitivity reaction on the active ingredient or any auxiliary ingredient of the approved product or the tetravalent HPV vaccine, it is forbidden; if there is hypersensitivity reaction symptom after the injection of the approved product or the tetravalent HPV vaccine, it shall not be vaccinated again.
How to choose bivalent, bivalent and bivalent vaccines?
Bivalent vaccine: for women aged 9 to 25 years. It can prevent infection by HPV16 and HPV18. According to international research data, more than 70% of cervical cancer is caused by these two viruses.
Tetravalent vaccine: suitable for women aged 20-45 years. It can prevent type 6, 11, 16, 18 HPV infection. Although HPV6 and HPV11 are not high risk HPV, they can cause genital condyloma acuminatum.
Bivalent vaccine: suitable for 16 to 26 year old women. According to the nine subtypes of HPV6, 11, 16, 18, 31, 33, 45, 52 and 58, the study shows that the nine valent vaccine can prevent 90% of cervical cancer.
You can choose different types of HPV vaccine according to your age and economic situation.